Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure

Veterinary Research

Volumn 41, Issue 1, 2010, Pages

  García Lastra, Rodrigo ^a   San Miguel, Beatriz ^a   Crespo, Irene ^a   Jorquera, Francisco ^a   Alvarez, Marcelino ^a   González Gallego, Javier ^a   Tuñón, María J ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Fulminant hepatic failure; Mitogen activated protein kinase; Nuclear factor kappa B; Rabbit hemorrhagic disease; Signal transducer and activator of transcription

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CASPASE 3; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD CHEMISTRY; ENZYME ACTIVATION; ENZYME ACTIVITY; FULMINANT HEPATIC FAILURE; GEL MOBILITY SHIFT ASSAY; HEMAGGLUTINATION; LAGOVIRUS; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS INDUCTION; VIRUS ISOLATION; WESTERN BLOTTING; ANIMAL; ANIMAL DISEASE; CALICIVIRUS INFECTION; CYTOLOGY; GENE EXPRESSION REGULATION; LIVER; METABOLISM; PHYSIOLOGY; RABBIT; VIROLOGY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; APOPTOSIS; CALICIVIRIDAE INFECTIONS; CYTOKINES; GENE EXPRESSION REGULATION; HEMORRHAGIC DISEASE VIRUS, RABBIT; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; RABBITS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 70450169732     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres/2009050     Document Type: Article

References (54)

1. Alonso C., Oviedo J.M., Martín-Alonso J.M., Díaz E., Boga J.A., Parra F., Programmed cell death in the pathogenesis of rabbit hemorrhagic disease, Arch. Virol. (1998) 143:321-332.
2. Arbadi S., Maier R.V., Mitogen-activated protein kinases, Crit. Care Med. (2002) 30:S74-S78.
3. Bélanger M., Butterworth R.F., Acute liver failure: A critical appraisal of available animal models, Metab. Brain Dis. (2005) 20:409-423.
4. Chen L.W., Chang W.J., Wang J.S., Hsu C.M., Thermal injury-induced peroxynitrite production and pulmonary inducible nitric oxide synthase expression depend on JNK/AP-1 signaling, Crit. Care Med. (2006) 34:142-150.
5. Chen W.Y., Ho K.C., Leu J.H., Liu K.F., Wang H.C., Kou G.H., Lo C.F., WSSV infection activates STAT in shrimp, Dev. Comp. Immunol. (2008) 32:1142-1150.
6. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., González-Gallego J., Quercetin decreases oxidative stress, NF-kappaB activation and iNOS overexpression in liver of streptozotocin induced diabetic rats, J. Nutr. (2005) 135:2299-2304.
7. Duechting A., Tschöpe C., Kaiser H., Lamkemeyer T., Tanaka N., Aberle S., et al., Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells, J. Virol. (2008) 82:7942-7952.
8. Ekstrand-Hammarström B., Osterlund C., Lilliehöök B., Bucht A., Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells, Clin. Exp. Immunol. (2007) 147:359-369.
9. Galun E., Zeira E., Pappo O., Peters M., Rose-John S., Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury, FASEB J. (2000) 14:1979-1987.
10. Gao B., Cytokines, STATs and liver disease, Cell. Mol. Immunol. (2005) 2:92-100.
11. García-Mediavilla M.V., Crespo I., Collado P.S., Esteller A., Sánchez-Campos S., Tuntild;ón M.J., González-Gallego J., Anti-inflammatory effect of the flavones quercetin and kaempferol in Chang Liver cells involves inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway, Eur. J. Pharmacol. (2007) 557:221-229.
12. Han C., Li G., Lim K., Defrances M.C., Gandhi C.R., Wu T., Transgenic expression of cyclooxygenase- 2 in hepatocytes accelerates endotoxin-induced acute liver failure, J. Immunol. (2008) 181: 8027-8035.
13. Ip Y.T., Davis R.J., Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development, Curr. Opin. Cell Biol. (1998) 10: 205-219.
14. Katsuma S., Mita K., Simada T., ERK- and JNKdependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection, J. Virol. (2007) 81:13700-13709.
15. Kim W.H., Hong F., Radaeva S., Jaruga B., Fan S., Gao B., STAT1 plays an essential role in LPS/Dgalactosamine- induced liver apoptosis and injury, Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 285:761-768.
16. Kolch W., Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions, Biochem. J. (2000) 351:289-305.
17. Kretzmann N.A., Fillmann H., Mauriz J.L., Marroni C.A., Marroni N., González-Gallego J., Tun tild;ón M.J., Effects of glutamine on pro-inflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in experimental colitis, Inflamm. Bowel Dis. (2008) 14:1504-1513.
18. Lee W.M., Acute liver failure in the United States, Semin. Liver Dis. (2003) 23:217-226.
19. Liu S.J., Xue H.P., Pu B.Q., Quia N.H., A new viral disease in rabbits, Anim. Husb. Vet. Med. (1984) 16:253-255.
20. Maeda S., Chang L., Li Z.W., Luo J.L., Leffert H., Karin M., IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha, Immunity (2003) 19:725-737.
21. Martínez-Flores S., Gutiérrez-Fernández B., Sánchez-Campos S., Gonzalez-Gallego J., Tun tild;ón M.J., Quercetin prevents nitric oxide production and nuclear factor kappa B activation in interleukin-1bactivated rat hepatocytes, J. Nutr. (2005) 135: 1359-1365.
22. Mauriz J.L., Matilla B., Culebras J.M., González P., González-Gallego J., Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat, Free Radic. Biol. Med. (2001) 31:1236-1244.
23. Meraz M.A., White J.M., Sheehan K.C., Bach C.A., Rodig S.J., Dighe A.S., et al., Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell (1996) 84:431-442.
24. Mikami O., Hepatic lesions in young rabbits experimentally infected with rabbit haemorrhagic disease virus, Res. Vet. Sci. (1999) 66:237-242.
25. Moreira A., Fraga C., Alonso M., Collado P.S., Zettler C., Marroni C., et al., Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats, Biochem. Pharmacol. (2004) 68:1939-1946.
26. Muto Y., Nouir-Aria K.T., Meager A., Alexander G.J., Edlleston A.L., Williams R., Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet (1988) 2:72-74.
27. Nakama T., Hirono S., Moriuchi A., Etoposide prevents apoptosis in mouse liver with D-galactosamine/ lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality, Hepatology (2001) 33:1441-1450.
28. Pan H., Xie J., Ye F., Gao S.J., Modulation of Kaposis's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple- mitogen-activated protein kinase pathways during primary infection, J. Virol. (2006) 80:5371-5382.
29. Panteva M., Korkaya H., Jameel S., Hepatitis viruses and the MAPK pathway: Is this a survival strategy?, Virus Res. (2003) 92:131-140.
30. Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., Ludwig S., Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression, PLoS Pathog. (2008) 4:e1000196.
31. Persico T., Savasi V., Ferrazzi E., Oneta M., Semprini A.E., Simoni G., Detection of human immunodeficiency virus-1 RNA and DNA by extractive and in situ PCR in unprocessed semen and seminal fractions isolated by semen-washing procedure, Hum. Reprod. (2006) 2:1525-1530.
32. Pestka S., The human interferon alpha species and receptors, Biopolymers (2000) 55:254-287.
33. Qiu Z., Kwon A.H., Tsuji K., Kamiyama Y., Okumura T., Hirao Y., Fibronectin prevents D-galactosamine/ lipopolysaccharide-induced lethal hepatic failure in mice, Shock (2006) 25:80-87.
34. Rutherford A., Chung R.T., Acute liver failure: Mechanisms of hepatocyte injury and regeneration, Semin. Liver Dis. (2008) 28:167-174.
35. Sánchez-Campos S., Á lvarez M., Culebras J.M., González-Gallego J., Tun tild;ón M.J., Pathogenic molecular mechanisms in an animal model of fulminant hepatic failure: rabbit hemorrhagic viral disease, J. Lab. Clin. Med. (2004) 144:215-222.
36. San-Miguel B., Á lvarez M., Culebras J.M., González-Gallego J., Tun tild;ón M.J., N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure, Apoptosis (2006) 11:1945-1957.
37. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., et al., JNK1 but not JNK2 promotes the development of steatohepatitis in mice, Hepatology (2006) 43:163-172.
38. Schwabe R.F., Bradham C.A., Uehara T., Hatano E., Bennett B.L., Schoonhoven R., Brenner D.A., c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration, Hepatology (2003) 37:824-832.
39. Stravitz R.T., Critical management decisions in patients with acute liver failure, Chest (2008) 134:1092-1102.
40. Streetz K., Leifeld L., Grundmann D., Ramakers J., Eckert J., Spengler U., et al., Tumor necrosis factor a in the pathogenesis of human and murine fulminant hepatic failure, Gastroenterology (2000) 119:446-460.
41. Suzuki Y.J., Forman H.J., Sevanian A., Oxidants as stimulators of signal transduction, Free Radic. Biol. Med. (1997) 22:269-285.
42. Takahashi K., Umehara Y., Umehara M., Nishimura A., Naruumi S., Toyoki Y., et al., Plasma exchange-based plasma recycling dialysis system as an artificial liver support, Ther. Apher. Dial. (2008) 12:264-270.
43. Takamura M., Matsuda Y., Yamagiwa S., Tamura Y., Honda Y., Suzuki S., et al., An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharideinduced hepatic failure by modulating BH3-only proteins, Life Sci. (2007) 80:1335-1344.
44. Taub R., Hepatoprotection via the IL-6/Stat3 pathway, J. Clin. Invest. (2003) 112:978-980.
45. Tung W.H., Sujn C.C., Hsieh H.L., Wang S.W., Horng J.T., Yang C.M., EV71 induces VCAM-1 expression via PDGF receptor, PI3-K/Akt, p38 MAPK, JNK and NF-kappa B in vascular smooth muscle cells, Cell. Signal. (2007) 19:2127-2137.
46. Tun tild;ón M.J., Sánchez-Campos S., García- Ferreras J., Alvarez M., Jorquera F., Gonzalez-Gallego J., Rabbit hemorrhagic viral disease: Characterization of a new animal model of fulminant liver failure, J. Lab. Clin. Med. (2003) 141:272-278.
47. Tun tild;ón M.J., Alvarez M., Culebras J.M., González- Gallego J., An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure, World J. Gastroenterol. (2009) 15:3086-3098.
48. Van De Kerkhove M.P., Hoekstra R., Chamuleau R.A., Van Gulik T.M., Clinical application of bioartificial liver support systems, Ann. Surg. (2004) 240:216-230.
49. Whitmarsh A.J., Davis R.J., Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. (1996) 74:589-607.
50. Vlotides G., Sörensen A.S., Kopp F., Zitzmann K., Cengic N., Brand S., et al., SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA, Biochem. Biophys. Res. Commun. (2004) 320:1007-1014.
51. Wolf D., Hallmann R., Sass G., Sixt M., Kusters S., Fregien B., et al., TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis, J. Immunol. (2001) 166:1300-1307.
52. Yamada Y., Kirillova I., Peschon J.J., Fausto N., Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor, Proc. Natl. Acad. Sci. USA (1997) 94:1441-1446.
53. Yeh C., Lin P.Y., Liao M.H., Liu H.J., Lee J.W., Chiu S.J., et al., TNF-a mediates pseudorabies virus-induced apoptosis via activation of p38 MAPK and JNK/SAPK signaling, Virology (2008) 381: 55-66.
54. Zhu H., Shang X., Terada N., Liu C., STAT3 induces anti-hepatitis C viral activity in liver cells, Biochem. Biophys. Res. Commun. (2004) 324:518-528.